Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway
Levy appointed executive vice chancellor for medical affairs, dean of WashU Medicine
Bruce D. Levy, MD, is an accomplished physician-scientist and a highly regarded leader in academic medicine
WashU’s economic impact totals $9.8 billion
University drew $1 billion in external funding that led to scientific advances, new jobs
WashU startups attract record-setting $1.7 billion in private-sector investment over past year
Capital accelerates commercialization of WashU discoveries into life-changing diagnostics, therapeutics and medical devices
Silva, Yang named fellows of National Academy of Inventors
Distinction recognizes innovators who are shaping future of the world
Inaugural WashU Medicine Dean’s Medals honor extraordinary contributions
Eight individuals recognized for their legacy to WashU Medicine, impact on the world
CBS News Sunday Morning: Promising clinical trials in Alzheimer’s prevention
In this national spotlight, CBS News chief medical correspondent Dr. Jon LaPook sits down with Randall J. Bateman, MD, to explore groundbreaking global clinical trials that are redefining the future of Alzheimer’s care — proving that continued research matters now more than ever.
Breast cancer startup founded by WashU Medicine researchers acquired by Lunit
Prognosia’s AI-based imaging tech could improve prevention, early detection of breast cancer